5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.31▲ | 4.28▲ | 4.26▲ | 4.25▲ | 3.17▲ |
MA10 | 4.28▲ | 4.24▲ | 4.27▲ | 3.86▲ | 2.38▲ |
MA20 | 4.26▲ | 4.27▲ | 4.33▲ | 3.18▲ | 1.93▲ |
MA50 | 4.28▲ | 4.25▲ | 3.99▲ | 2.21▲ | 1.92▲ |
MA100 | 4.34▲ | 3.95▲ | 3.51▲ | 1.87▲ | 3.37▲ |
MA200 | 4.24▲ | 3.43▲ | 2.76▲ | 1.98▲ | 6.98▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.018▲ | 0.005▲ | -0.024▼ | 0.103▲ | 0.320▲ |
RSI | 69.322▲ | 60.039▲ | 59.838▲ | 74.417▲ | 77.493▲ |
STOCH | 74.603 | 51.442 | 27.821 | 85.471▲ | 80.134▲ |
WILL %R | 0.000▲ | -22.581▲ | -38.462 | -7.792▲ | -5.143▲ |
CCI | 231.746▲ | 77.567 | 58.657 | 115.934▲ | 190.266▲ |
BBANDS | $IMRX Bollinger Bands Expanding | Set Alert |
Wednesday, July 09, 2025 11:20 PM
Immuneering Corporation (NASDAQ: IMRX) has been granted a U.S. composition of matter patent for atebimetinib, a once-daily oral cancer drug designed to overcome resistance and deliver longer ...
|
Wednesday, July 09, 2025 05:00 AM
Newly issued U.S. composition of matter patent expected to provide exclusivity into 2042, with subsequent opportunity for patent term extension - - First U.S. patent granted on a deep cyclic inhibitor ...
|
Tuesday, July 01, 2025 05:00 PM
DIANA HAUSMAN, a director at $IMRX, bought 3,000 shares of the company on 07-02-2025 for an estimated $10,873. This trade was reported by Quiver Quantitative using data from a recent SEC filing.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 4.28 | 4.515 | 4.14 | 4.42 | 806,407 |
10/07/25 | 4.49 | 4.59 | 4.18 | 4.33 | 907,506 |
09/07/25 | 4.06 | 4.60 | 4.01 | 4.45 | 1,989,884 |
08/07/25 | 4.115 | 4.15 | 3.9211 | 4.00 | 752,305 |
07/07/25 | 3.50 | 4.1698 | 3.43 | 4.05 | 2,065,407 |
03/07/25 | 3.69 | 3.72 | 3.31 | 3.45 | 908,546 |
02/07/25 | 3.46 | 3.69 | 3.45 | 3.59 | 708,067 |
01/07/25 | 3.32 | 3.565 | 3.22 | 3.44 | 827,698 |
30/06/25 | 3.57 | 3.63 | 3.20 | 3.37 | 1,029,914 |
27/06/25 | 3.22 | 3.8734 | 3.14 | 3.53 | 2,758,527 |
|
|
||||
|
|
||||
|
|